Your browser does not seem to support JavaScript. As a result, your viewing experience will be diminished, and you have been placed in read-only mode.

Please download a browser that supports JavaScript, or enable it if it's disabled (i.e. NoScript).

NOVO — Januar 2022

19 Indlæg 1 Posters 0 Visninger

J Offline
J Offline
Jazzz

wrote on sidst redigeret af

#10

Har haft aktien i 23 år.. så hvad kursen gør i Januar 2022.. not very interesting. Men hvad selskabet gør, for at forblive interessant de næste 20 år.. det er interessant. Og de fortsætter med at imponerer. Så jeg beholder mine tyve tønder land..
1 Reply Last reply

0
L Offline
L Offline
lahn1

wrote on sidst redigeret af

#11

Drop tog fart igår, var det den sidste krampetrækning eller skal den i 604 før det vender. Sidder i hvert fald og tripper med den ene finger på købsknappen og den and på knappen over hos Gmab.
1 Reply Last reply

0
P Offline
P Offline
ProinvestorNEWS

wrote on sidst redigeret af

#12

Novo Nordisk indgår forlig i sag uden at betale sagsøgere - GENT https://www.proinvestor.com/investornyt/766116/novo-nordisk-indgar-forlig-i-sag-uden-at-betale-sagsogere-gent
1 Reply Last reply

0
P Offline
P Offline
ProinvestorNEWS

wrote on sidst redigeret af

#13

Novo/SHB: Kursmålet sænkes til 650 kr. fra 745 kr. - GENT https://www.proinvestor.com/investornyt/767906/novo-shb-kursmalet-saenkes-til-650-kr-fra-745-kr-gent
1 Reply Last reply

0
P Offline
P Offline
ProinvestorNEWS

wrote on sidst redigeret af

#14

Novo/SHB: Kursmålet sænkes til 650 kr. fra 745 kr. - NY https://www.proinvestor.com/investornyt/767915/novo-shb-kursmalet-saenkes-til-650-kr-fra-745-kr-ny
1 Reply Last reply

0
F Offline
F Offline
Fandel

wrote on sidst redigeret af

#15

Novo Nordisk lancerer Semaglutid i pilleform i Indien
1 Reply Last reply

0
P Offline
P Offline
ProinvestorNEWS

wrote on sidst redigeret af

#16

Novo/Nykredit Markets: Kursmål sænkes til 700 kr. fra 750 kr.
https://www.proinvestor.com/investornyt/768582/novo-nykredit-markets-kursmal-saenkes-til-700-kr-fra-750-kr
1 Reply Last reply

0
P Offline
P Offline
ProinvestorNEWS

wrote on sidst redigeret af

#17

Novo/Liberum: Anbefaling sænkes til "sælg" fra "hold"
https://www.proinvestor.com/investornyt/770213/novo-liberum-anbefaling-saenkes-til-saelg-fra-hold
1 Reply Last reply

0
S Offline
S Offline
Svingtraderen

wrote on sidst redigeret af

#18

Novo Nordisk/DNB: Anbefaling hæves til "køb" fra "hold"

Novo Nordisk har fået løftet anbefalingen til "køb" fra "hold" af DNB, skriver PLX.AI.

Kursmålet er uændret 740 kr.
1 Reply Last reply

0
P Offline
P Offline
ProinvestorNEWS

wrote on sidst redigeret af

#19

Novo Nordisk/DNB: Anbefaling hæves til "køb" fra "hold" - NY
https://www.proinvestor.com/investornyt/771671/novo-nordisk-dnb-anbefaling-haeves-til-kob-fra-hold-ny
1 Reply Last reply

0
B Offline
B Offline
bibob

wrote on sidst redigeret af

#20

Just a moment...

(www.fiercepharma.com)
1 Reply Last reply

0

Hello! It looks like you're interested in this conversation, but you don't have an account yet.

Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

With your input, this post could be even better 💗

Tilmeld Log ind